Back to Search
JOHN KRYSTAL, M.D.
M.D.
Psychiatry Physician
NPI: 1336226240Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
027473(CT)
Research & Publications (20)
Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism".
PMID 18070245·Alcohol Clin Exp Res·2008
2-rct
Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects.
PMID 15309376·Psychopharmacology (Berl)·2005
3-trial
What's missing in posttraumatic stress disorder research? Studies of human postmortem tissue.
PMID 15801380·Psychiatry·2004
8-other
Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients.
PMID 12888778·Neuropsychopharmacology·2003
3-trial
NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.
PMID 12955285·Psychopharmacology (Berl)·2003
6-review
Commentary: first, do no harm. Then, do some good: ethics and human experimental psychopharmacology.
PMID 12227233·Isr J Psychiatry Relat Sci·2002
8-other
Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia.
PMID 19460458·Drug Discov Today·2009
6-review
Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience.
PMID 19332037·Brain Res·2009
6-review
It is time to take a stand for medical research and against terrorism targeting medical scientists.
PMID 18371494·Biol Psychiatry·2008
7-preclinical
Capitalizing on extrasynaptic glutamate neurotransmission to treat antipsychotic-resistant symptoms in schizophrenia.
PMID 18694665·Biol Psychiatry·2008
6-review
Neuroplasticity as a target for the pharmacotherapy of psychiatric disorders: new opportunities for synergy with psychotherapy.
PMID 17916459·Biol Psychiatry·2007
8-other
The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia.
PMID 17197373·Neurotox Res·2006
6-review
Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment.
PMID 16952998·Arch Gen Psychiatry·2006
6-review
Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism.
PMID 16395307·Neuropsychopharmacology·2006
4-observational
NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy.
PMID 14684445·Ann N Y Acad Sci·2003
6-review
N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability.
PMID 12804700·Pharmacol Ther·2003
6-review
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments.
PMID 11986998·Mol Psychiatry·2002
6-review
Current perspectives on the pathophysiology of schizophrenia, depression, and anxiety disorders.
PMID 11349473·Med Clin North Am·2001
6-review
Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions.
PMID 10664830·Biol Psychiatry·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 950 CAMPBELL AVE, 151D
WEST HAVEN, CT 06516 - Phone
- (203) 937-4790
Quick Facts
- NPI
- 1336226240
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile